Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Buckeyes

Rank: President [?]

Points: 2956 [?]

Votes: 31 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

in response to

Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

KOO-KOO2

posted on Aug 23, 2022 07:39AM

I would think that an FDA Type C meeting would be a material event, right??

Pretty important to the strategy and direction, and future, of the company. With the potential to impact stock pps up or down.

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply